BioCube Financial Statements From 2010 to 2025

BICB Stock  USD 0.0002  0.00  0.00%   
BioCube financial statements provide useful quarterly and yearly information to potential BioCube investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BioCube financial statements helps investors assess BioCube's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BioCube's valuation are summarized below:
BioCube does not presently have any fundamental signals for analysis.
Check BioCube financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioCube's main balance sheet or income statement drivers, such as , as well as many indicators such as . BioCube financial statements analysis is a perfect complement when working with BioCube Valuation or Volatility modules.
  
This module can also supplement various BioCube Technical models . Check out the analysis of BioCube Correlation against competitors.

BioCube Company Price To Earning Analysis

BioCube's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current BioCube Price To Earning

    
  (0.65) X  
Most of BioCube's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioCube is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, BioCube has a Price To Earning of -0.65 times. This is 103.56% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The price to earning for all United States stocks is 102.26% higher than that of the company.

BioCube Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BioCube's current stock value. Our valuation model uses many indicators to compare BioCube value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioCube competition to find correlations between indicators driving BioCube's intrinsic value. More Info.
BioCube is rated second in current valuation category among its peers. It is rated third in shares outstanding category among its peers creating about  11.69  of Shares Outstanding per Current Valuation. Comparative valuation analysis is a catch-all model that can be used if you cannot value BioCube by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioCube's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About BioCube Financial Statements

BioCube stakeholders use historical fundamental indicators, such as BioCube's revenue or net income, to determine how well the company is positioned to perform in the future. Although BioCube investors may analyze each financial statement separately, they are all interrelated. For example, changes in BioCube's assets and liabilities are reflected in the revenues and expenses on BioCube's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BioCube. Please read more on our technical analysis and fundamental analysis pages.
BioCube, Inc., a development stage company, focuses on the development and marketing of lithium ion batteries in North America. The company was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. Biocube is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in BioCube Pink Sheet

BioCube financial ratios help investors to determine whether BioCube Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioCube with respect to the benefits of owning BioCube security.